Cited 0 times in
RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김상운 | - |
dc.contributor.author | 김성훈 | - |
dc.contributor.author | 김영태 | - |
dc.contributor.author | 남은지 | - |
dc.contributor.author | 이영주 | - |
dc.contributor.author | 이용재 | - |
dc.contributor.author | 이정윤 | - |
dc.date.accessioned | 2023-06-02T01:10:33Z | - |
dc.date.available | 2023-06-02T01:10:33Z | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 1048-891X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194710 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Lippincott Williams & Wilkins | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Obstetrics and Gynecology (산부인과학교실) | - |
dc.contributor.googleauthor | Young Joo Lee | - |
dc.contributor.googleauthor | Yong Jae Lee | - |
dc.contributor.googleauthor | Eun Ji Nam | - |
dc.contributor.googleauthor | Sang Wun Kim | - |
dc.contributor.googleauthor | Sunghoon Kim | - |
dc.contributor.googleauthor | Young Tae Kim | - |
dc.contributor.googleauthor | Jung-Yun Lee | - |
dc.identifier.doi | 10.1136/ijgc-2022-igcs.347 | - |
dc.contributor.localId | A00526 | - |
dc.contributor.localId | A00595 | - |
dc.contributor.localId | A00729 | - |
dc.contributor.localId | A01262 | - |
dc.contributor.localId | A06232 | - |
dc.contributor.localId | A05165 | - |
dc.contributor.localId | A04638 | - |
dc.relation.journalcode | J01115 | - |
dc.identifier.eissn | 1525-1438 | - |
dc.identifier.url | https://ijgc.bmj.com/content/32/Suppl_3/A154.1 | - |
dc.contributor.alternativeName | Kim, Sang Wun | - |
dc.contributor.affiliatedAuthor | 김상운 | - |
dc.contributor.affiliatedAuthor | 김성훈 | - |
dc.contributor.affiliatedAuthor | 김영태 | - |
dc.contributor.affiliatedAuthor | 남은지 | - |
dc.contributor.affiliatedAuthor | 이영주 | - |
dc.contributor.affiliatedAuthor | 이용재 | - |
dc.contributor.affiliatedAuthor | 이정윤 | - |
dc.citation.volume | 32 | - |
dc.citation.number | suppl 3 | - |
dc.citation.startPage | A154 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, Vol.32(suppl 3) : A154, 2022-12 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.